1
Steven W Goldstein, Michael R Makowski, Roger B Ruggeri, Ronald T Wester: Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines. Pfizer, Peter C Richardson, Gregg C Benson, A Dean Olson, October 31, 2000: US06140342 (19 worldwide citation)

Cholesteryl ester transfer protein inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and trig ...


2
Steven W Goldstein, Michael R Makowski, Roger B Ruggeri, Ronald T Wester: Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines. Pfizer, Peter C Richardson, Gregg C Benson, A Dean Olson, March 26, 2002: US06362198 (12 worldwide citation)

Cholesteryl ester transfer protein inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and trig ...


3
Goldstein Steven Wayne, Makowski Michael Raymond, Ruggeri Roger Benjamin, Wester Ronald Thure: 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines hydroxy substitue, Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines. Pfizer Products, Pfizer Products, SMART & BIGGAR, August 8, 2006: CA2282183

Cholesteryl ester transfer protein inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and trig ...